Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/met...

por Wilson, Florence R., Varu, Abhishek, Mitra, Debanjali, Cameron, Chris, Iyer, Shrividya
Publicado 2017

Phosphorylated (pT371)TRF1 is recruited to sites of DNA damage to facilitate homologous recombination and checkpoint activation

por McKerlie, Megan, Walker, John R., Mitchell, Taylor R. H., Wilson, Florence R., Zhu, Xu-Dong
Publicado 2013

TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies

por Ho, Angus, Wilson, Florence R., Peragine, Stephanie L., Jeyanthan, Kajaparan, Mitchell, Taylor R. H., Zhu, Xu-Dong
Publicado 2016

Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis

por Wilson, Florence R., Coombes, Megan E., Wylie, Quinlan, Yurchenko, Mariya, Brezden-Masley, Christine, Hutton, Brian, Skidmore, Becky, Cameron, Chris
Publicado 2017

Indirect treatment comparison of lurbinectedin versus other second-line treatments for small-cell lung cancer

por Hanvesakul, Raj, Rengarajan, Badri, Naveh, Navit, Boccuti, Anne, Park, Julie E, Adeyemi, Adekemi, Caisip, Clyde, Jansen, Jeroen P, Wilson, Florence R
Publicado 2023

Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis

por Wilson, Florence R., Coombes, Megan E., Brezden-Masley, Christine, Yurchenko, Mariya, Wylie, Quinlan, Douma, Reuben, Varu, Abhishek, Hutton, Brian, Skidmore, Becky, Cameron, Chris
Publicado 2018

Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%

por Freemantle, Nick, Xu, Yingxin, Wilson, Florence R., Guyot, Patricia, Chen, Chieh-I, Keeping, Sam, Konidaris, Gerasimos, Chan, Keith, Kuznik, Andreas, Atsou, Kokuvi, Glowienka, Emily, Pouliot, Jean-Francois, Gullo, Giuseppe, Rietschel, Petra
Publicado 2022

Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer

por Feliciano, Josephine Louella, McLoone, Dylan, Xu, Yingxin, Quek, Ruben G.W., Kuznik, Andreas, Pouliot, Jean-Francois, Gullo, Giuseppe, Rietschel, Petra, Guyot, Patricia, Konidaris, Gerasimos, Chan, Keith, Keeping, Sam, Wilson, Florence R., Freemantle, Nick
Publicado 2023